Cefaclor is a second-generation oral cephalosporin with improved stability against certain beta-lactamases, used for respiratory tract, ear and urinary tract infections. Simson Pharma's Cefaclor reference standard and impurities support compendial testing including the pharmacopoeially important delta-3-cefaclor degradation product.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cefaclor Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.